AN2 Therapeutics (ANTX) Ownership - Who owns AN2 Therapeutics?
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform... Show more
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ANTX showed earnings on August 12, 2025. You can read more about the earnings report here.